These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15148067)

  • 21. Tolerability of indacaterol, a novel once-daily beta2-agonist, in patients with asthma: a randomized, placebo-controlled, 28-day safety study.
    Yang WH; Martinot JB; Pohunek P; Beier J; Magula D; Cameron R; Owen R; Higgins M
    Ann Allergy Asthma Immunol; 2007 Dec; 99(6):555-61. PubMed ID: 18219838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.
    Greenstone IR; Ni Chroinin MN; Masse V; Danish A; Magdalinos H; Zhang X; Ducharme FM
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005533. PubMed ID: 16235409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomised trial of an inhaled beta2 agonist, inhaled corticosteroid and their combination in the treatment of asthma.
    Hancox RJ; Cowan JO; Flannery EM; Herbison GP; McLachlan CR; Wong CS; Taylor DR
    Thorax; 1999 Jun; 54(6):482-7. PubMed ID: 10335000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
    Aziz I; Hall IP; McFarlane LC; Lipworth BJ
    J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial.
    Israel E; Chinchilli VM; Ford JG; Boushey HA; Cherniack R; Craig TJ; Deykin A; Fagan JK; Fahy JV; Fish J; Kraft M; Kunselman SJ; Lazarus SC; Lemanske RF; Liggett SB; Martin RJ; Mitra N; Peters SP; Silverman E; Sorkness CA; Szefler SJ; Wechsler ME; Weiss ST; Drazen JM;
    Lancet; 2004 Oct 23-29; 364(9444):1505-12. PubMed ID: 15500895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhaled steroid/long-acting beta 2 agonist combination products provide 24 hours improvement in lung function in adult asthmatic patients.
    Lötvall J; Langley S; Woodcock A
    Respir Res; 2006 Aug; 7(1):110. PubMed ID: 16919161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of theophylline on tolerance to the bronchoprotective actions of salmeterol in asthmatics in vivo.
    Cheung D; Wever AM; de GOEIJ JA; de GRAAFF CS; Steen H; Sterk PJ
    Am J Respir Crit Care Med; 1998 Sep; 158(3):792-6. PubMed ID: 9731006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol.
    Kalra S; Swystun VA; Bhagat R; Cockcroft DW
    Chest; 1996 Apr; 109(4):953-6. PubMed ID: 8635376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tolerance to bronchodilation during treatment with long-acting beta-agonists, a randomised controlled trial.
    Haney S; Hancox RJ
    Respir Res; 2005 Sep; 6(1):107. PubMed ID: 16168062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subsensitivity of bronchodilator and systemic beta 2 adrenoceptor responses after regular twice daily treatment with eformoterol dry powder in asthmatic patients.
    Newnham DM; Grove A; McDevitt DG; Lipworth BJ
    Thorax; 1995 May; 50(5):497-504. PubMed ID: 7597661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A dose-ranging study of the bronchodilator effects of abediterol (LAS100977), a long-acting β2-adrenergic agonist, in asthma; a Phase II, randomized study.
    Singh D; Pujol H; Ribera A; Seoane B; Massana E; Astbury C; Ruiz S; de Miquel G
    BMC Pulm Med; 2014 Nov; 14():176. PubMed ID: 25398689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benralizumab for patients with mild to moderate, persistent asthma (BISE): a randomised, double-blind, placebo-controlled, phase 3 trial.
    Ferguson GT; FitzGerald JM; Bleecker ER; Laviolette M; Bernstein D; LaForce C; Mansfield L; Barker P; Wu Y; Jison M; Goldman M;
    Lancet Respir Med; 2017 Jul; 5(7):568-576. PubMed ID: 28545978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased perception of dyspnea by inhalation of short acting beta2 agonist in patients with asthma of varying severity.
    Jang AS; Choi IS
    Ann Allergy Asthma Immunol; 2000 Jan; 84(1):79-83. PubMed ID: 10674569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Asthma control during and after cessation of regular beta 2-agonist treatment.
    Wahedna I; Wong CS; Wisniewski AF; Pavord ID; Tattersfield AE
    Am Rev Respir Dis; 1993 Sep; 148(3):707-12. PubMed ID: 8103655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bronchodilator response in relation to beta2-adrenoceptor haplotype in patients with asthma.
    Taylor DR; Epton MJ; Kennedy MA; Smith AD; Iles S; Miller AL; Littlejohn MD; Cowan JO; Hewitt T; Swanney MP; Brassett KP; Herbison GP
    Am J Respir Crit Care Med; 2005 Sep; 172(6):700-3. PubMed ID: 15976384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness.
    Rosenthal RR; Busse WW; Kemp JP; Baker JW; Kalberg C; Emmett A; Rickard KA
    Chest; 1999 Sep; 116(3):595-602. PubMed ID: 10492259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined inhaled anticholinergics and beta2-agonists for initial treatment of acute asthma in children.
    Plotnick LH; Ducharme FM
    Cochrane Database Syst Rev; 2000; (4):CD000060. PubMed ID: 11034671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adverse respiratory effect of acute β-blocker exposure in asthma: a systematic review and meta-analysis of randomized controlled trials.
    Morales DR; Jackson C; Lipworth BJ; Donnan PT; Guthrie B
    Chest; 2014 Apr; 145(4):779-786. PubMed ID: 24202435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Addition of intravenous aminophylline to beta2-agonists in adults with acute asthma.
    Parameswaran K; Belda J; Rowe BH
    Cochrane Database Syst Rev; 2000; (4):CD002742. PubMed ID: 11034753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid onset of tolerance to the bronchoprotective effect of salmeterol.
    Bhagat R; Kalra S; Swystun VA; Cockcroft DW
    Chest; 1995 Nov; 108(5):1235-9. PubMed ID: 7587422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.